Shareholding disclosure

Essex Woodlands Health Ventures VIII, LLC

Declared position

15.89%

Threshold

Crossed upwards

Timeline

Published

12.08.2015

Transaction

04.08.2015

Voting rights breakdown

Voting rights acquired15.89%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAF8A00018

Beneficial owner

Essex Woodlands Health Ventures VIII, LLC

Declared address

Essex Woodlands Health Ventures VIII, LLC, The Woodlands, TX 77380

End of Lock-up period on August 4, 2015 pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). All voting rights of the listed funds are managed and controlled by Essex Woodlands Health Ventures VIII, LLC. Essex Woodlands Health Ventures VIII, LLC is the general partner of Essex Woodlands Health Ventures VIII, LP. Essex Woodlands Health Ventures VIII, LP is the general partner of Essex Woodlands Health Ventures Fund VIII, LP (direct owner), Essex Woodlands Health Ventures Fund VIII-A, LP (direct owner) and Essex Woodlands Health Ventures Fund VIII-B, LP (direct owner).

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Essex Woodlands Health Ventures VIII, LLC

Molecular Partners AG12.08.2015TAF8A00018

Disclosure summary

Essex Woodlands Health Ventures VIII, LLC disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 12.08.2015, at 15.89% of voting rights. Notice category: Single shareholder.

Disclosed position

15.89%

Voting rights acquired

Voting rights acquired15.89%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Essex Woodlands Health Ventures VIII, LLC disclosed a holding in Molecular Partners AG, published on 12.08.2015.

Publication date12.08.2015

Transaction date04.08.2015

Issuing companyMolecular Partners AG

Beneficial ownerEssex Woodlands Health Ventures VIII, LLC

Declared addressEssex Woodlands Health Ventures VIII, LLC, The Woodlands, TX 77380

CategorySingle shareholder

Voting rights acquired15.89%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAF8A00018

Conditions

End of Lock-up period on August 4, 2015 pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). All voting rights of the listed funds are managed and controlled by Essex Woodlands Health Ventures VIII, LLC. Essex Woodlands Health Ventures VIII, LLC is the general partner of Essex Woodlands Health Ventures VIII, LP. Essex Woodlands Health Ventures VIII, LP is the general partner of Essex Woodlands Health Ventures Fund VIII, LP (direct owner), Essex Woodlands Health Ventures Fund VIII-A, LP (direct owner) and Essex Woodlands Health Ventures Fund VIII-B, LP (direct owner).

Source: SIX Exchange Regulation · Publication date: 12.08.2015

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open